CLINICAL_TRIALS
trial_result
· 2025-03-21
Clinical Trial Update: Monthly Injectable BUP for MA Use Disorder (MURB) Trial [Phase 2]
Summary
Phase 2 trial evaluating monthly injectable buprenorphine for methamphetamine use disorder has been terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Madhukar H. Trivedi, MD | Conditions: Methamphetamine-dependence | Phase 2 | Status: TERMINATED | Results posted: 2025-03-21